OBBeC.com

Cambridge, MA (OBBeC) - CLC bio has today announced the signing of a collaborative agreement with the J. Craig Venter Institute, a not-for profit genomic-focused research institute. The agreement consists of a multi-year site license for the entire CLC bio bioinformatics suite of products.

According to the announcement, the goal is to implement CLC bio's enterprise solution as a scientific platform across all JCVI sites. This enterprise solution will provide different research projects at JCVI with a coherent integration layer and a standardized way of developing custom software and specialized algorithms.

“JCVI will benefit from implementing this enterprise solution, as it is a full enterprise platform that integrates, supports, and enhances workflows across different technologies and geographical sites,” states Granger Sutton, Senior Director of Informatics. “CLC bio's software platform impressed our evaluators with its advanced features and intuitive, user-friendly interface.”

The enterprise solution CLC bio will be implementing at JCVI contains both server structure and support for all major database formats. This ensures a smart and efficient solution for sharing centralized bioinformatics data in a client/server architecture, where the server contains one or more databases and the clients are CLC bio's workbenches.

CLC bio's solution is a technological gateway that efficiently accesses all data and analysis in a single platform. With CLC bio's enterprise solution all proprietary algorithms and solutions developed at JCVI can be accessed from the same bioinformatics platform, ensuring a streamlined workflow with minimal overhead and no tedious time-wasting procedures. CLC bio's Developer Kit will enable JCVI to build targeted plug-ins for their internal use, while allowing JCVI to interact based on the same platform with worldwide collaborators.